Increasing genetic testing for cancer patients
Part of Cancer, Genetic & congenital clinical trials.
This trial aims to increase the use of genetic testing (germline testing) among cancer patients by working with healthcare providers like oncologists and nurses. If you are an oncology care team member treating adults with breast, pancreatic, or colorectal cancer, this study may be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a member of an oncology care team (for example, an oncologist, advanced practice provider, or nurse navigator).
- You treat adult patients with breast cancer, pancreatic cancer, or colorectal cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers free genetic testing to cancer patients and their healthcare providers. It aims to help people who may not have easy access to genetic testing understand their cancer risk.
This study helps clinics roll out cancer genetic counseling services for people who may have inherited cancer risk. If you may need genetic testing for hereditary breast or colon cancer, you can be interviewed about your experience with these services.
This study tests whether a special program led by oncology nurses can help more people with solid tumor cancers get genetic testing. If you are starting a new treatment and have not had genetic testing before, this program may help you learn about your cancer risks and treatment options.
This study helps people with cancer learn about genetic testing for hereditary cancer. It aims to improve access to testing and support for those who may have an inherited risk.
This study helps prostate cancer survivors get genetic testing for inherited cancer risk. It aims to make testing easier to access and understand.
This study uses genetic testing of your tumor to find specific mutations and match you with targeted therapies, aiming to improve outcomes for advanced cancers with poor prognosis. If you have pancreatic, liver, or triple negative breast cancer and are starting treatment, this trial may help you access personalized treatment options.
Hear when a new Hereditary Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.